Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.
02:22pm, Friday, 02'nd Aug 2024
Sometimes the best way to jump into an industry like biotech is to follow the popular trades. Though that may go against the common advice of avoiding hype cycles and the fear of missing out, seeing w
Can Pfizer (PFE) Run Higher on Rising Earnings Estimates?
01:21pm, Friday, 02'nd Aug 2024
Pfizer (PFE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
PFE vs. NVO: Which Stock Is the Better Value Option?
12:46pm, Friday, 02'nd Aug 2024
Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Novo Nordisk (NVO). But which of these two stocks offers value investors a bett
Are Investors Undervaluing Pfizer (PFE) Right Now?
10:46am, Friday, 02'nd Aug 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
2 Dividend Stocks To Watch In August 2024
10:09am, Friday, 02'nd Aug 2024
Dividend stocks to watch in the stock market today.
7 Subdued Blue-Chip Stocks That Will Reward Patient Investors
07:45am, Friday, 02'nd Aug 2024
An undeniable fact about equities is that it always remains in a long-term uptrend. In the last ten years, the S&P 500 Index has delivered total returns at a CAGR of 12.75%.
The weight loss space is dominated by Eli Lilly and Novo Nordisk, which produce the leading medications. Viking Therapeutics, Altimmune, Pfizer, and Roche are all looking to enter the red-hot weight l
Is Pfizer Winning Its $43 Billion Bet?
04:10am, Friday, 02'nd Aug 2024
Pfizer beat pharma records when its annual revenue soared past $100 billion in 2022, thanks to its coronavirus vaccine and treatment. As demand for these products slowed, revenue dropped -- so the big
Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore
10:00am, Thursday, 01'st Aug 2024
The market consistently offers opportunities in value stocks for bargain hunters willing to do the work and take risks. Most of the work is done here for you as I have identified value stocks that are
Fed Signals Likely Rate Cuts In September: Buy These 3 High-Yield Blue-Chip Stocks Today
09:55am, Thursday, 01'st Aug 2024
Fed Chairman Jerome Powell hinted at a possible rate cut at the September meeting, reinforcing investor expectations. Powell expresses confidence in achieving a soft landing, as inflation trends towar
Dividend Harvesting Portfolio Week 178: $17,800 Allocated, $1,612.87 In Projected Dividends
09:00am, Thursday, 01'st Aug 2024
Alphabet and Tesla had negative reactions to Q2 earnings reports. Economic data showed PCE increased 0.1% MoM, while consumer confidence declined for the 4th consecutive month. The Dividend Harvesting
Pfizer Stock: It May Be Just The Beginning Of A Solid Rally
06:54am, Thursday, 01'st Aug 2024
I initiated a "Buy" rating on Pfizer stock in February 2024, and since then, it's aging well. I believe the recovery rally in PFE stock may be just the beginning. The cost management initiatives seem
Pfizer Just Confirmed It's a Dividend Investor's Dream Stock
05:50am, Thursday, 01'st Aug 2024
Pfizer's management is committed to maintaining and growing the dividend. The big drugmaker's dividend should be even more secure thanks to coming bottom-line improvements.
Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening
04:20am, Thursday, 01'st Aug 2024
CEO Albert Bourla doesn't see the company making a big acquisition for a GLP-1 drugmaker. Pfizer has close to $70 billion in long-term debt on its books.
Pfizer Just Did This for the First Time in 6 Quarters. Time to Buy?
04:10am, Thursday, 01'st Aug 2024
Pfizer's earnings soared earlier in the pandemic, thanks to its blockbuster coronavirus vaccine and treatment. Since, revenue has dropped -- but Pfizer has made major efforts to return to growth.
